Amplification of Autologous Epidermal Cells to Repair Large Area Deep Wounds

Recruiting now · Not applicable

Conditions studied: Autologous Epidermal Cell Transplantation

In brief

Autologous epidermal cell transplantation is based on the principle and technology of skin tissue engineering, and is performed by cutting small pieces of autologous skin from patients, isolating and culturing and expanding them, and then transplanting them to the patient's wounds to repair the damage.

Key facts

Study ID

NCT05882110

Run by

Yicheng Ma

People needed

100

Starts

2023-10-01

Expected to finish

2026-12-31

Last updated by the study team

2025-04-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a body surface trauma of 30% TBSA or more and a wound that requires at least 2 weeks to repair as assessed by the clinician

You may not qualify if…

• Patient body surface trauma area less than 30% TBSA

Where it is running

• Yicheng Ma — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.